Other

Alaven Pharmaceutical, LLC

Sciele Pharma, Inc.

Venkataraman, Bala

Guthrie, Michael

Brown, Lindsey

Patel, Daxa

Bala Venkataraman

Michael Guthrie

Michael J Guthrie

Lindsey Brown

Daxa Patel

Alan Roberts

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

Reduced irritant enema for the treatment of inflammatory bowel disease (IBD)

A composition comprising heme iron and/or heme iron polypeptide in combination with ionic iron(s) and/or chelated iron(s). Administration of effective dosages of the present composition provides a method for treating and/or preventing iron deficiency anemia, and the physiological, biochemical, morphological, and behavioral manifestations symptomatic of same.

Composition and method for treating iron deficiency anemia

Reduced irritant enema for treatment of inflammatory bowel disease (IBD)

The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food.

Method for increasing the bioavailability of glycopyrrolate

Growing community of inventors

Alpharetta, GA, United States of America

Bala Venkataraman